Payments to Acquire Property, Plant, and Equipment of GYRE THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
GYRE THERAPEUTICS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • GYRE THERAPEUTICS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $122,000, a 47% decline year-over-year.
  • GYRE THERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $1,190,000, a 49% decline from 2024.
  • GYRE THERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $2,315,000, a 73% decline from 2023.
  • GYRE THERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $8,517,000, a 71% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

GYRE THERAPEUTICS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,190,000 -$1,125,000 -49% 01 Jan 2025 31 Dec 2025 10-K 13 Mar 2026 2025 FY
2024 $2,315,000 -$6,202,000 -73% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2026 2025 FY
2023 $8,517,000 +$3,532,000 +71% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $4,985,000 +$4,146,000 +494% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $839,000 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2019 $64,000 -$312,000 -83% 01 Jan 2019 31 Dec 2019 10-K 20 Feb 2020 2019 FY
2018 $376,000 +$353,000 +1535% 01 Jan 2018 31 Dec 2018 10-K 20 Feb 2020 2019 FY
2017 $23,000 -$445,000 -95% 01 Jan 2017 31 Dec 2017 10-K 08 Mar 2019 2018 FY
2016 $468,000 +$196,000 +72% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018 2017 FY
2015 $272,000 +$268,000 +6700% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2017 2016 FY
2014 $4,000 -$37,000 -90% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2015 2014 FY
2013 $41,000 -$292,000 -88% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016 2015 FY
2012 $333,000 -$1,098,000 -77% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $1,431,000 -$1,880,000 -57% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014 2013 FY
2010 $3,311,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY

GYRE THERAPEUTICS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $122,000 -$109,000 -47% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $231,000 -$1,511,000 -87% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $1,742,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2020 $17,000 +$2,000 +13% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $15,000 -$183,000 -92% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $198,000 +$195,000 +6500% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $3,000 -$86,000 -97% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $89,000 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q1 2013 $70,000 +$24,000 +52% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $46,000 -$552,000 -92% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q1 2011 $598,000 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.